JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details


300 *	Tue, 7/31/2012, 8:30 AM - 10:20 AM	CC-Room 28E
Analysis of Biomarker Data — Contributed Papers
Biopharmaceutical Section , Biometrics Section , Section on Statistics in Epidemiology
Chair(s): Aloka Chakravarty, FDA/CDER
8:35 AM	Standardized Statistical Framework for Comparison of Biomarkers — Danielle J Harvey, University of California at Davis ; Clifford Jack Jr, Mayo Clinic ; Norbert Schuff, University of California at San Francisco ; Michael Weiner, University of California at San Francisco ; Laurel Beckett, University of California at Davis
8:50 AM	Strategies for Identifying Predictive Biomarkers in Clinical Trials Using Variable Importance — Ilya Lipkovich, Quintiles, Inc. ; Alex Dmitrienko, Quintiles, Inc.
9:05 AM	Leveraging Early Biomarker Data to Assess Futility in an Oncology Test-of-Concept Study — Robin Mogg, Merck Research Laboratories ; Devan Mehrotra, Merck Research Laboratories
9:20 AM	Biomarker Assay Data: How Well Quantified Is the Limit of Quantification? — Ying Guo, Merck
9:35 AM	A Phase II Design with Direct Assignment Option in Stage II for Initial Marker Validation — Ming-Wen An, Vassar College ; Sumithra J. Mandrekar, Mayo Clinic ; Daniel J. Sargent, Mayo Clinic
9:50 AM	Statistical Methodology for Generalized Linear Models with Censored Covariates — Paul Bernhardt, North Carolina State University ; Huixia Judy Wang, North Carolina State University ; Daowen Zhang, North Carolina State University
10:05 AM	Floor Discussion

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.